Total Payments
$17,571
2024 Payments
$913.54
Companies
9
Transactions
77
Medicare Patients
1,111
Medicare Billing
$58,471
Payment Breakdown by Category
Other$15,150 (86.2%)
Food & Beverage$1,411 (8.0%)
Travel$971.20 (5.5%)
Education$39.52 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15,150 | 13 | 86.2% |
| Food and Beverage | $1,411 | 58 | 8.0% |
| Travel and Lodging | $971.20 | 5 | 5.5% |
| Education | $39.52 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $17,133 | 60 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $102.56 | 6 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $100.31 | 4 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $58.58 | 1 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $51.65 | 1 | $0 (2021) |
| Lexicon Pharmaceuticals, Inc. | $47.48 | 2 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $33.44 | 1 | $0 (2022) |
| Abbott Laboratories | $22.99 | 1 | $0 (2021) |
| Xeris Pharmaceuticals, Inc. | $21.40 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $913.54 | 7 | Janssen Pharmaceuticals, Inc ($830.72) |
| 2023 | $5,342 | 12 | Janssen Pharmaceuticals, Inc ($5,277) |
| 2022 | $9,766 | 33 | Janssen Pharmaceuticals, Inc ($9,635) |
| 2021 | $1,550 | 25 | Janssen Pharmaceuticals, Inc ($1,390) |
All Payment Transactions
77 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/30/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $6.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/29/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $28.60 | General |
| 05/22/2024 | AstraZeneca Pharmaceuticals LP | — | Education | In-kind items and services | $39.52 | General |
| 05/14/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/30/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Rare Disease | ||||||
| 03/29/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $800.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/28/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $9.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/05/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/07/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Rare Disease | ||||||
| 10/04/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/29/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/30/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 08/14/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Rare Disease | ||||||
| 07/25/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $6.28 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/20/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/20/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $72.25 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/01/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/19/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $4.84 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/23/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/08/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/08/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/17/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $33.44 | General |
| Category: Cardio-renal | ||||||
| 11/11/2022 | Xeris Pharmaceuticals, Inc. | GVOKE PFS (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Diabetes | ||||||
| 11/09/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/28/2022 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 225 | 1,334 | $50,892 | $12,979 |
| 2022 | 4 | 284 | 1,347 | $56,194 | $15,882 |
| 2021 | 4 | 253 | 1,387 | $47,342 | $14,463 |
| 2020 | 6 | 349 | 1,346 | $62,165 | $15,147 |
Total Patients
1,111
Total Services
5,414
Medicare Billing
$58,471
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0250 | Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | Facility | 2023 | 121 | 1,178 | $25,906 | $5,849 | 22.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 51 | 51 | $13,484 | $4,268 | 31.7% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2023 | 41 | 93 | $6,975 | $1,748 | 25.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 12 | 12 | $4,527 | $1,114 | 24.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 80 | 80 | $21,040 | $7,216 | 34.3% |
| G0250 | Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | Facility | 2022 | 123 | 1,177 | $23,540 | $5,579 | 23.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 16 | 16 | $6,064 | $1,582 | 26.1% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 2022 | 65 | 74 | $5,550 | $1,504 | 27.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 82 | 83 | $22,156 | $7,388 | 33.3% |
| G0250 | Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | Facility | 2021 | 126 | 1,259 | $21,403 | $5,904 | 27.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 12 | 12 | $2,364 | $646.71 | 27.4% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 33 | 33 | $1,419 | $524.37 | 37.0% |
| G0250 | Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | Facility | 2020 | 118 | 1,100 | $18,700 | $6,039 | 32.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 59 | 60 | $16,084 | $3,956 | 24.6% |
| G0249 | Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the | Office | 2020 | 60 | 74 | $15,318 | $2,177 | 14.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 28 | 28 | $6,126 | $1,388 | 22.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 16 | 16 | $3,152 | $818.64 | 26.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 14 | 14 | $1,862 | $460.85 | 24.8% |
| G0250 | Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | Office | 2020 | 54 | 54 | $923.00 | $308.64 | 33.4% |
About Carla Huber, ARNP
Carla Huber, ARNP is a Nurse Practitioner healthcare provider based in Cedar Rapids, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1912193129.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Carla Huber, ARNP has received a total of $17,571 in payments from pharmaceutical and medical device companies, with $913.54 received in 2024. These payments were reported across 77 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($15,150).
As a Medicare-enrolled provider, Huber has provided services to 1,111 Medicare beneficiaries, totaling 5,414 services with total Medicare billing of $58,471. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Cedar Rapids, IA
- Active Since 09/20/2007
- Last Updated 11/26/2018
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1912193129
Products in Payments
- XARELTO (Drug) $17,235
- ANDEXXA (Biological) $60.79
- LifeVest (Device) $58.58
- JARDIANCE (Drug) $51.65
- Kerendia (Drug) $33.44
- MitraClip System (Device) $22.99
- GVOKE PFS (Drug) $21.40
- Inpefa (Drug) $18.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Cedar Rapids
Sashi Solomon, Arnp, ARNP
Nurse Practitioner — Payments: $3,452
Nurse Practitioner $3,452
Sarah Norris, Arnp, ARNP
Nurse Practitioner — Payments: $3,114
Nurse Practitioner $3,114
Paula Stultz, Arnp, ARNP
Nurse Practitioner — Payments: $2,784
Nurse Practitioner $2,784
Melissa Coulter, Arnp, ARNP
Nurse Practitioner — Payments: $2,604
Nurse Practitioner $2,604
Dr. Margaret Stracuzzi, Arnp, ARNP
Nurse Practitioner — Payments: $2,523
Nurse Practitioner $2,523
Rikka Burroughs, Arnp, ARNP
Nurse Practitioner — Payments: $2,118
Nurse Practitioner $2,118